Search
Xtant Medical Holdings Inc
XTNTAdd to Watchlist
0.320USD
-0.007-2.14%
Close 09-18 16:00（ET）
45.59MMarket Cap
24.70P/E TTM
After-hours 16:10 (ET)0.320USD-0.005-1.54%
After-hours 16:10 (ET)Xtant Medical Holdings Inc (XTNT) Stock Price Target & Forecast
Analyst Rating
Based on 3 analysts giving stock ratings to Xtant Medical Holdings Inc in the past month.
Buy
0 Strong Buy
3 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
1.033USD+222.92%
XTNT Analyst Recommendation Trends
In the current month, XTNT has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. XTNT average Analyst price target in the last month is 1.033.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
1
1
1
1
1
1
3
2
2
2
2
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
2
3
3
3
2
2
2
XTNT Analyst Rating for Peer Comparison
Updated: Sep 17, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Dexcom Inc
DXCM
13
13
4
0
0
30
Stryker Corp
SYK
11
13
6
0
0
30
Medtronic PLC
MDT
9
10
11
0
0
30
Abbott Laboratories
ABT
11
12
6
0
0
29
Zimmer Biomet Holdings Inc
ZBH
2
6
21
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Guardant Health Inc
GH
12
13
2
0
0
27
Insulet Corp
PODD
7
8
12
0
0
27
Repligen Corp
RGEN
5
14
3
0
0
22
Tandem Diabetes Care Inc
TNDM
4
8
10
0
0
22
Financial Forecasting
Based on analysts' estimates, XTNT EPS is projected to reach -0.023 in FY2026Q3, following reported EPS of -0.067 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.01
-0.02
-0.02
-0.02
-0.00
Actual
0.00
-0.02
-0.07
--
--
Surprise
+108.20%
-32.33%
-235.55%
--
--
FAQs
What is Xtant Medical Holdings Inc's expected revenue for the next quarter?
Xtant Medical Holdings Inc's expected revenue is 25.51M.
What is Xtant Medical Holdings Inc's price target?
Analysts forecast that Xtant Medical Holdings Inc's price target is USD 1.03, with the highest forecast at USD 1.50 and the lowest forecast at USD 0.60.
How have Xtant Medical Holdings IncXTNT's recent earnings per share performed?
The market expectation was USD -0.07, while Xtant Medical Holdings IncXTNT's earnings per share (EPS) for the previous quarter was USD -0.02. EPS for the next quarter is expected at USD -0.02.
What is the analyst rating for Xtant Medical Holdings Inc?
Based on the ratings of Xtant Medical Holdings Inc's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.